Pyridazinone compounds as phosphodiesterase inhibitors and methods of treating disorders
US8916566B2 · kind B2 · utility
2Cited by
5References
37Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 4, 2010 |
| Grant date | Dec 23, 2014 |
| Priority date | — |
| Expiry date | Jan 27, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/2059
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a compound which has the effect of PDE inhibition, and which is useful as a medicament for preventing or treating schizophrenia or so on.A compound of formula (I0):
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.